Key facts
- Notable investors include Datong Qikai Investment, Shanghai Huangpu Lead Venture Capital Partnership.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Silk Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Silk Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Silk Biotechnology
Manufacturer of biomedical materials and clinical devices intended for implantable healthcare applications. The company offers protein-based material development, structured design of implantable devices, experimental validation systems, technical consulting services, regulatory compliance support, and scalable production processes, enabling medical markets to maintain across diverse therapeutic contexts with long-term operational consistency.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Silk Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Silk Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Silk Biotechnology in its N-PORT filings yet. We sweep new filings monthly.